You're going to hear more about "aspirin resistance

May 2003

You're going to hear more about "aspirin resistance."

Tests suggest that about 10% of patients are resistant to aspirin's antiplatelet effects...and therefore might not benefit from using low-dose aspirin to prevent cardiovascular disease.

Now a study suggests that these patients are up to 3 times more likely to die of cardiovascular disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote